SCHEMBL5481700

SCHEMBL5481700

OC[C@@]12CCCN1CCNC2

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
SOS1 Q07889 1/20 0.33
SOS2 Q07890 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL338063 1.00 SOS1 (0.33) SOS1SOS2
SCHEMBL23288551 0.87
SCHEMBL9562288 0.79 CHRNA7 (0.36)
SCHEMBL19358804 0.77 HCN1 (0.30)
SCHEMBL25417165 0.77
Hydrochloric Acid SCHEMBL27209964 0.77 CHRNA7 (0.35)
SCHEMBL16757277 0.74 MEN1 (0.39)
SCHEMBL31208861 0.74 SOS1 (0.32) SOS1SOS2
SCHEMBL8221048 0.74 GNAI3 (0.33) SOS1SOS2
SCHEMBL5888096 0.72 OPRM1 (0.33)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070037817-A1 Acetylenic piperazines as metabotropic glutamate receptor antagonists ASTRAZENECA AB (SE) 2007-02-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070037817-A1 Acetylenic piperazines as metabotropic glutamate receptor antagonists GRM1, GRM5, GRIN1 SOS1 4107/4885SOS2 4747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.